v3.22.1
Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Income Statement [Abstract]    
Federal grants $ 603,098 $ 250,576
Operating expenses:    
Research and development 3,140,096 284,378
General and administrative 2,265,806 490,471
Total operating expenses 5,405,902 774,849
Loss from operations (4,802,804) (524,273)
Other income (expense):    
Change in fair value of derivative liabilities (39,585)
Change in fair value of convertible notes 2,767,178
Change in fair value of liability classified warrants 2,794,398
Loss on debt conversions (1,702,642)
Interest expense (15,021) (347,834)
Other income and expense, net 7,966
Total other income (expense), net 3,851,879 (387,419)
Net income (loss) (950,925) (911,692)
Net income (loss) attributable to noncontrolling interests 182 (3,961)
Deemed dividend related to warrants down round provision 715,579
Net loss attributable to common stockholders $ (1,666,686) $ (907,731)
Net loss per share:    
Net loss per share attributable to common stockholders, basic and diluted $ (0.06) $ (0.06)
Weighted average common shares outstanding, basic and diluted 27,287,618 15,834,185

Source